Morony, S <br/><br/>
A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3.  [electronic resource] 

 -  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research  Sep 1999 
 - 1478-85 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0884-0431 
<br/><br/><label>Standard No.: </label>10.1359/jbmr.1999.14.9.1478  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Bone Resorption<br/>Bone and Bones--diagnostic imaging<br/>Calcitriol--pharmacology<br/>Calcium--blood<br/>Cell Count--drug effects<br/>Glycoproteins--chemistry<br/>Humans<br/>Hypercalcemia--prevention & control<br/>Interleukin-1--pharmacology<br/>Isomerism<br/>Male<br/>Mice<br/>Osteoclasts--drug effects<br/>Osteoprotegerin<br/>Parathyroid Hormone--blood<br/>Parathyroid Hormone-Related Protein<br/>Proteins--pharmacology<br/>Radiography<br/>Receptors, Cytoplasmic and Nuclear<br/>Receptors, Tumor Necrosis Factor--metabolism<br/>Tumor Necrosis Factor-alpha--pharmacology<br/>Weight Loss--drug effects